These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 35533197)
21. N-terminal B-type natriuretic peptide concentrations are similarly increased by 30 minutes of moderate and brisk walking in patients with coronary artery disease. Scharhag J; Herrmann M; Weissinger M; Herrmann W; Kindermann W Clin Res Cardiol; 2007 Apr; 96(4):218-26. PubMed ID: 17323015 [TBL] [Abstract][Full Text] [Related]
23. Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof-of-concept, randomised, precision-medicine, prevention trial. The Heart OMics in AGing (HOMAGE) trial. Pellicori P; Ferreira JP; Mariottoni B; Brunner-La Rocca HP; Ahmed FZ; Verdonschot J; Collier T; Cuthbert JJ; Petutschnigg J; Mujaj B; Girerd N; González A; Clark AL; Cosmi F; Staessen JA; Heymans S; Latini R; Rossignol P; Zannad F; Cleland JGF Eur J Heart Fail; 2020 Sep; 22(9):1711-1723. PubMed ID: 31950604 [TBL] [Abstract][Full Text] [Related]
24. N-terminal pro-B-type natriuretic peptide levels and early outcome after cardiac surgery: a prospective cohort study. Cuthbertson BH; Croal BL; Rae D; Gibson PH; McNeilly JD; Jeffrey RR; Smith WC; Prescott GJ; Buchan KG; El-Shafei H; Gibson GA; Hillis GS Br J Anaesth; 2009 Nov; 103(5):647-53. PubMed ID: 19713279 [TBL] [Abstract][Full Text] [Related]
25. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial. Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071 [TBL] [Abstract][Full Text] [Related]
26. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?). Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350 [TBL] [Abstract][Full Text] [Related]
27. Utility of NT-proBNP as an objective marker of postoperative heart failure after coronary artery bypass surgery: a prospective observational study. Jiang H; Holm J; Friberg Ö; Vanky F; Vidlund M; Tajik B; Yang Y; Svedjeholm R Perioper Med (Lond); 2021 Jul; 10(1):21. PubMed ID: 34253255 [TBL] [Abstract][Full Text] [Related]
28. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease]. Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970 [TBL] [Abstract][Full Text] [Related]
29. Utility of Preoperative N-Terminal Pro-B-Type Natriuretic Peptide in the Prognosis of Coronary Artery Bypass Grafting. Wang J; Liu H; Zeng J; Su X; Zhao Y; Zheng Z Am J Cardiol; 2023 Aug; 201():131-138. PubMed ID: 37385164 [TBL] [Abstract][Full Text] [Related]
30. A comparison of intraoperative goal-directed intravenous administration of crystalloid versus colloid solutions on the postoperative maximum N-terminal pro brain natriuretic peptide in patients undergoing moderate- to high-risk noncardiac surgery. Reiterer C; Kabon B; Taschner A; Zotti O; Kurz A; Fleischmann E BMC Anesthesiol; 2020 Aug; 20(1):192. PubMed ID: 32753064 [TBL] [Abstract][Full Text] [Related]
31. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction. Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760 [TBL] [Abstract][Full Text] [Related]
32. Use of preoperative natriuretic peptides and echocardiographic parameters in predicting new-onset atrial fibrillation after coronary artery bypass grafting: a prospective comparative study. Gibson PH; Croal BL; Cuthbertson BH; Rae D; McNeilly JD; Gibson G; Jeffrey RR; Buchan KG; El-Shafei H; Hillis GS Am Heart J; 2009 Aug; 158(2):244-51. PubMed ID: 19619701 [TBL] [Abstract][Full Text] [Related]
33. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation. Kristensen SL; Jhund PS; Mogensen UM; Rørth R; Abraham WT; Desai A; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV; Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29018174 [TBL] [Abstract][Full Text] [Related]
34. Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension. Chin KM; Rubin LJ; Channick R; Di Scala L; Gaine S; Galiè N; Ghofrani HA; Hoeper MM; Lang IM; McLaughlin VV; Preiss R; Simonneau G; Sitbon O; Tapson VF Circulation; 2019 May; 139(21):2440-2450. PubMed ID: 30982349 [TBL] [Abstract][Full Text] [Related]
35. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. Toblli JE; Lombraña A; Duarte P; Di Gennaro F J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147 [TBL] [Abstract][Full Text] [Related]
36. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome. Buchner S; Debl K; Barlage S; Griese D; Fredersdorf S; Jeron A; Lubnow M; Müller T; Muders F; Holmer S; Riegger GA; Luchner A Clin Chem Lab Med; 2010 Jun; 48(6):875-81. PubMed ID: 20441480 [TBL] [Abstract][Full Text] [Related]
39. Impact of intravenous exenatide infusion for perioperative blood glucose control on myocardial ischemia-reperfusion injuries after coronary artery bypass graft surgery: sub study of the phase II/III ExSTRESS randomized trial. Besch G; Perrotti A; Salomon du Mont L; Puyraveau M; Ben-Said X; Baltres M; Barrucand B; Flicoteaux G; Vettoretti L; Samain E; Chocron S; Pili-Floury S Cardiovasc Diabetol; 2018 Nov; 17(1):140. PubMed ID: 30384842 [TBL] [Abstract][Full Text] [Related]
40. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF. Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP; Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]